cranial nerve palsy. Routine laboratory studies were within normal limits. Serology was negative for HIV. Her magnetic resonance imaging brain [ Figures 1 and 2 ] revealed an isointense lesion on T2-weighted images with brilliant enhancement on contrast involving right middle cranial fossa base with cavernous sinus involvement and destruction of petrous bone. A possibility of skull base meningioma was considered.
INTRODUCTION
Leiomyosarcoma (LMS) is a relatively rare soft tissue sarcoma that arises from smooth muscle cells. These tumors are commonly encountered in uterus, stomach, small intestine and retro peritoneum. However, rarely these tumors arise in brain from pluripotent mesenchymal stem cells of the dura mater or cerebral blood vessel epithelium. [1] Dura based lesions may clinically and radiologically mimic meningioma's. We hereby describe a very rare case of primary LMS in immunocompetent patient with involvement of cavernous sinus.
CASE REPORT
A 55-year-old female presented with severe neuralgic pain in the right half of the face in ophthalmic distribution of trigeminal nerve of 3 months duration and right sixth cranial nerve palsy of 15 days duration. There were no features of raised intracranial pressure. There was no history of smoking, intravenous drug abuse or sexual promiscuity. On examination, she had sensory loss in right V1 and V2 distribution, mild wasting of the temporalis and masseter muscles along with right sixth
A B S T R A C T
Intracranial leiomyosarcoma (LMS) are uncommon malignancies and usually encountered after systemic metastases. Limited cases of primary intracranial LMSs have been reported in the literature. It mostly affects immunocompromised individuals in association with Epstein-Barr virus infection. This is the unusual first case being reported of primary LMS in immunocompetent patient with involvement of cavernous sinus.
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Primary extradural leiomyosarcoma involving cavernous sinus in an immunocompetent patient
Based on the histological findings and IHC, diagnosis of LMS involving the cavernous sinus was made.
Postoperatively, patient recovered with no new neurological deficits. Her postoperative computed tomography (CT) scan showed residual tumor in the right cavernous sinus [ Figure 5 ]. Staging CT scan of the chest, abdomen and pelvis and positron emission tomography scan didn't reveal any other site of involvement by tumor. The patient tested serologically negative for HIV, herpes simplex virus and Epstein-Barr virus (EBV) antibodies. The patient was referred to cancer hospital for adjuvant therapy.
DISCUSSION
Intracranial soft tissue sarcomas are rare tumors that account for only 0.1-0.2% of all central nervous system (CNS) tumors. [2] Most intracranial soft tissue sarcomas represent metastases and primary sarcomas arising in brain are quite rare. Among the sarcomas, children are preferentially affected with rhabdomyosarcoma and adult's usually have malignant fibrous histiocytoma and chondrosarcoma. [3] LMS is a rare intracranial malignant tumor that mostly arises in the dura and parasellar region. Age of presentation in previous case reports ranged from 2 to 73 years. [4, 5] There is usually no sex predilection and the median duration of symptoms before presentation is nearly 4 months. [6] Intraparenchymal location of the tumor is mostly observed in systemic metastases and primary examples are rare. Systemic LMSs have a predilection for hematogenous spread to CNS and most frequent primary sites include uterus and gastrointestinal tract followed by retroperitoneum, lung and heart. An interesting association has been observed for occurrence of primary dural CNS LMSs in immunocompromised patients with latent EBV infection. [7] The latter is commonly associated with HIV and organ transplantation. Previous exposure to radiation has also been associated with LMS.
The present case is the first to be reported of primary intracranial LMS in immunocompetent patient involving cavernous sinus. Literature search revealed only 10 cases of primary intracranial LMS in immunocompetent adults [ Table 1 ].
Intracranial LMS need to be distinguished from malignant meningioma, myofibrosarcoma and fibrosarcoma. Surgery, radiotherapy, and chemotherapy are the current choices of treatment for primary intracranial LMS. However, the prognosis of this tumor remains poor with the longest survival reported in literature being 32 months. [6] Patient survival is limited due to several reasons. Gross resection of tumor with adequate surgical margins isn't achievable in most cases and the behavior of tumor is usually aggressive with limited response to chemotherapeutic drugs. Our patient was referred to cancer hospital for adjuvant radiotherapy and chemotherapy. However, she died within 5 months due to systemic complications.
CONCLUSION
Our patient is a rare case of primary extradural LMS involving cavernous sinus in an immunocompetent patient. Although intracranial LMSs are more common in immunodeficient individuals, increasing cases are being encountered in immune competent patients as well. Research studies are needed to identify the etiologic factors responsible for intracranial LMSs in immunocompetent individuals.
